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Abstract
Background: ACOG states meconium stained amniotic fluid (MSAF) as one of the historical indicators of perinatal
asphyxia. Thick meconium along with other indicators is used to identify babies with severe intrapartum asphyxia. Lactate
creatinine ratio (L: C ratio) of 0.64 or higher in first passed urine of babies suffering severe intrapartum asphyxia has been
shown to predict Hypoxic Ischaemic Encephalopathy (HIE). Literature review shows that meconium is passed in distress
and thin meconium results from mixing and dilution over time, which may be hours to days. Thin meconium may thus
be used as an indicator of antepartum asphyxia. We tested L: C ratios in a group of babies born through thin and thick
meconium, and for comparison, in a group of babies without meconium at birth.
Methods: 86 consecutive newborns, 36 to 42 weeks of gestation, with meconium staining of liquor, were recruited for
the study. 52 voided urine within 6 hours of birth; of these 27 had thick meconium and 25 had thin meconium at birth.
42 others, who did not have meconium or any other signs of asphyxia at birth provided controls. Lactate and creatinine
levels in urine were tested by standard enzymatic methods in the three groups.
Results: Lactate values are highest in the thin MSAF group followed by the thick MSAF and controls. Creatinine was
lowest in the thin MSAF, followed by thick MSAF and controls. Normal babies had an average L: C ratio of 0.13 (± 0.09).
L: C ratio was more among thin MSAF babies (4.3 ± 11.94) than thick MSAF babies (0.35 ± 0.35). Median L: C ratio was
also higher in the thin MSAF group. Variation in the values of these parameters is observed to be high in the thin MSAF
group as compared to other groups. L: C ratio was above the cutoff of 0.64 of Huang et al in 40% of those with thin
meconium. 2 of these developed signs of HIE with convulsions (HIE Sarnat and Sarnat Stage II) during hospital stay. One
had L: C Ratio of 93 and the other of 58.6. A smaller proportion (20%) of those with thick meconium had levels above
the cutoff and 2 developed HIE and convulsions with L: C ratio of 1.25 and 1.1 respectively.
Conclusion: In evolving a cutoff of L: C ratios that would be highly sensitive and specific (0.64), Huang et al studied it
in a series of babies with severe intrapartum asphyxia. Our study shows that the specificity may not be as good if babies
born through thin meconium are also included. L: C ratios are much higher in babies with thin meconium. It may be that
meconium alone is not a good indicator of asphyxia and the risk of HIE. However, if the presence of meconium implies
asphyxia then perhaps a higher cut-off than 0.64 is needed. L: C ratios should be tested in a larger sample that includes
babies with thin meconium, before L: C ratios can be applied universally.
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Background
Anoxic injury to the fetal brain as a result of birth asphyxia
may lead to cerebral palsy. Intrapartum asphyxia alone
however accounts for only a small proportion of cases of
cerebral palsy (CP) [1,2]. In a consensus statement, the
Australian and New Zealand Perinatal Societies have esti-
mated that around 10% of cases of cerebral palsy stem
from adverse intrapartum events [3]. In the majority, the
cause of CP is antepartum [4]. Intrinsic fetal causes like
intracranial malformations and inborn errors of metabo-
lism contribute to a miniscule number of cases.
The American College of Obstetricians and Gynecologists
(ACOG) has laid down compulsory criteria, all of which
must be met for establishing a plausible link between
intrapartum asphyxia and neurological deficit. These are –
profound acidaemia, Apgar score of 3 or less for more
than 5 minutes, neonatal neurological sequelae (like sei-
zures), and multiorgan system dysfunction [5].
The manifestations of antepartum asphyxia are poorly
understood and most are not specifically related to brain
damage. Reduced fetal movements, non-reassuring fetal
heart rate patterns [6](FHRT), fetal ECG [7], fetal scalp
blood sampling [8] and in-utero passage of meconium [9]
are some of them. Lack of specificity of these indicators
limits their use in medicolegal issues. Epidemiologically,
as most damage in cases of cerebral palsy is antepartum,
each of these 'nonspecific' indicators need careful scrutiny
to identify antepartum asphyxia.
As with intrapartum asphyxia, most babies with antepar-
tum asphyxia escape damage. In only a few babies with
asphyxia is there neonatal encephalopathy. Some of these
may progress to Hypoxic ischaemic encephalopathy
(HIE), and only a subset of those with HIE eventually sus-
tain brain damage [10].
12%–22% of all pregnancies are complicated by meco-
nium, but 50% of those who develop HIE had been born
through meconium stained amniotic fluid [11](MSAF).
Meconium in labor may indicate fetal distress or asphyxia.
There are at least three theories explaining meconium pas-
sage: in-utero relaxation of the anal sphincter [12] vagal
stimulation [12,13] and postmaturity [14]. Numerous
investigators have concluded that presence of meconium
in the amniotic fluid is a sign of fetal hypoxia or acidosis
[15-19].
Recent studies [20,21] have reported much higher levels
of fetal erythropoetin, and lower fetal oxygen saturation
[22] in pregnancies complicated by meconium and con-
cluded that in-utero passage of meconium reflects chronic
asphyxia. In summary, it is understood that, (though not
and independent predictor of poor neurodevelopmental
outcome), intrauterine passage of meconium may reflect
an asphyxial event.
Some babies pass meconium due to intrauterine infec-
tions, chorioamnionitis, and premature rupture of mem-
branes and up to35% of postmature babies (born after 42
weeks of gestation) may pass meconium [23]. Clearly,
asphyxia cannot alone be implicated for in-utero meco-
nium passage especially in post-mature babies and in the
presence of intrauterine infections.
When freshly passed, meconium is a thick, viscous, green
liquid [24] except perhaps in cases of fetal diarrhea due to
Listeriosis. Meconium stains the amniotic fluid and
presents as thick meconium. The consistency is altered
over time by dilution and fetal movement [25] resulting
in thin meconium. Arguably, thinner and more uniformly
mixed meconium has been retained in the amniotic fluid
for a longer duration (hours to days)[25], than meconium
that appears thick. The exact time interval between pas-
sage of meconium to its complete dilution is not available
in literature.
After excluding postmature babies and those who are
likely to be infected, we assume for purposes of this study
that all babies who pass meconium have asphyxia. Those
who pass thick meconium are assumed to have intrapar-
tum asphyxia and those with thin meconium to have
antepartum asphyxia. We tested the premise with Lactate:
Creatinine ratio (L: C ratio)- a proven marker of asphyxia.
Combining lactate- a product of anaerobic metabolism
resulting from hypoxia, and creatinine-a measure of renal
function whose excretion is reduced in renal compromise
caused by ischaemia, L: C ratio in urine has been shown to
predict HIE and future neurodevelopmental outcome.
Huang et al [26] studied a group of severely asphyxiated
newborns, identified by well-established criteria of peri-
natal asphyxia (thick meconium among others) and
reported that L: C ratio of 0.64 or higher in first passed
urine was highly specific for HIE [5].
We used L: C ratio as a marker to study antepartum and
intrapartum asphyxia. We tested L: C ratio in a group of
term babies, born to mothers without a history of intrau-
terine infection, through thin and thick meconium, and
for comparison in a group of normal babies without
meconium.
Methods
The study was conducted at St Stephen's Hospital, Delhi
India. It is a 600 bedded tertiary level postgraduate teach-
ing hospital, conducting 5000 deliveries annually,
equipped with a 75 bedded nursery and level III neonatal
intensive care unit.BMC Pediatrics 2006, 6:13 http://www.biomedcentral.com/1471-2431/6/13
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Of 1415 deliveries between January to March 2000 at our
hospital, 212 babies were born through MSAF. Some of
these mothers were referred from other centers in labor
and antenatal records were not available. These mothers
were excluded. The number of eligible mothers was thus
112. From among these, post term mothers and mothers
with a history suggestive of infection were excluded. 86
consecutive newborns of 36–42 weeks of gestation with
meconium staining of amniotic fluid, without evidence of
maternal infection (indicated by fever, premature rupture
of membranes, or foul smelling vaginal discharge), were
thus subjects of the study. None of the babies had any
renal abnormality, or other congenital anomalies detected
at antenatal ultrasonographic examination. 28 babies did
not pass urine within six hours. Urine from 6 babies could
not be analyzed as volume available, after centrifugation
(to remove the heavy precipitates in neonatal urine), stor-
age, and transportation to the laboratory was found inad-
equate. Finally more than 1 ml of clear supernatant urine
passed within six hours of birth was available for testing
from 52 babies and this group of samples was analyzed.
Figure 1 shows a flow diagram of how the cases were
recruited.
Meconium was categorized into thick or thin, based on its
naked-eye appearance, by the pediatrician or nurse
attending the delivery. Among the babies whose urine was
available, 27 had had thick meconium and 25 had thin
meconium. For comparison, we collected samples of
urine, passed within six hours of birth from 42 normal
babies born at more than 36 weeks of gestation with no
staining of the amniotic fluid. These babies had Apgar
score of at least eight at five minutes. This was essentially
a 'convenience sample' collected from babies of consent-
ing parents who met the above criteria to act as controls.
The pediatric unit looked after all babies during their hos-
pital stay. Blood gas analysis was done when indicated as
per hospital protocol. For staging of HIE, the classification
of Sarnat and Sarnat [28] was used. The score uses clinical
parameters like heart rate, respiration, pupils, conscious-
ness, muscle tone, posture and neonatal reflexes and elec-
troencephalographic (EEG) criteria, as well as incidence of
seizures not attributable to transient metabolic derange-
ments. Whereas a detailed clinical scoring, and incidence
of seizures was recorded in all suspected babies, EEG was
not done. The hospital research committee approved the
study. Informed consent was obtained from parents of
babies participating in the study, prior to urine collection.
Samples of the first voided urine were centrifuged and
clear supernatant was transferred to 1-ml plain Greiner
cones (Greiner Labortechnik GmbH, Maybachstra, Frick-
enhausen, Germany) and preserved at minus 32°C in a
deep freezer. All samples were tested together for urine
lactate and creatinine by conventional enzymatic method
by a Randox™ kit (Randox Laboratories, Co. Antrim, UK)
on Olympus (Reply) autoanalyzer (Olympus Optical Co.
Ltd, Shinjuku-ku, Tokyo, Japan).
The oxidase enzyme in the kit converts lactate to pyruvic
acid and hydrogen peroxide, which results in oxidative
conversion of chromogen to produce a coloured dye with
absorption maximum at 540 nm, the amount of which is
directly proportional to the amount of lactate in the sam-
ple. Creatinine in urine was measured by the concentra-
tion of a yellow orange colored dye formed from the
reaction with Picric acid under alkaline conditions, which
had its absorption maximum at 500 nm.
The continuous and quantitative variables like birth
weight, gestational age were compared among the three
groups of subjects, namely normal babies, those with thin
and thick MSAF, using the analysis of variance technique.
Lactate, creatinine and L: C ratio values were analyzed
with ANOVA after logarithmic transformation followed
by Bonferroni adjustment for multiple comparisons. The
Bonferroni correction is part of the 'one-way' command of
Stata ver 8.0, which gives the actual p values for each spe-
cific comparison. It, like any other multiple comparison
procedure, is relevant only when one finds a significant
difference among the groups being compared by ANOVA.
Bonferroni correction is a more conservative procedure
than other multiple comparison procedures. Thus, if Bon-
ferroni correction leads to a significant result, we can be
more confident of the significance of the result.
Qualitative variables like sex, Apgar score (categorization
into two groups – <6 at 5 minutes and ≥ 6 at 5 minutes),
maternal and postnatal problems (again categorized-
present or absent) were compared among the three groups
by Fisher's exact test. All the statistical analyses were car-
ried out using STATA 8.0. p – value of less than 0.05 was
considered to be statistically significant.
Results
Table 1 shows the population characteristics of the three
groups of babies: those born with thin MSAF, those with
thick MSAF and normal babies. They were comparable in
terms of gestational age, gender distribution, and Apgar
scores at 5 minutes. Problems during gestation like preg-
nancy induced hypertension, cephalopelvic dispropor-
tion, and fetal heart rate abnormalities, were associated
more with thick meconium stained babies compared to
controls (p < 0.01) than with thin meconium compared
to controls. Four mothers in the control group had ante-
natal problems. Two mothers had gestational diabetes
(on diet control), along with hypertensive (on treatment),
one had hypertension alone (on treatment) and one
mother had leaking of nearly 20 hours duration. NormalBMC Pediatrics 2006, 6:13 http://www.biomedcentral.com/1471-2431/6/13
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Schematic representation of the study population to show how the cases were recruited for the study Figure 1
Schematic representation of the study population to show how the cases were recruited for the study.
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babies on the average weighed 120 grams more than
babies with thin MSAF and 230 grams more than babies
with thick MSAF. However, only thick MSAF babies
weighed significantly lower compared to controls (Bon-
ferroni corrected p = 0.02). Difference in the birth weights
between thin and thick MSAF babies was not statistically
significant (Bonferroni corrected p = 0.69).
Thick MSAF babies had three cases of maternal hyperten-
sion, 3 cases of fetal heart rate abnormality (FHRT), two
cases of breech delivery, and one case each of cephalopel-
vic disproportion, and intrauterine growth retardation.
Thin MSAF Babies had fewer problems in the mothers
with two cases of hypertension and one case of cepha-
lopelvic disproportion. Two babies born through thick
MSAF who developed HIE had history of maternal hyper-
tension, neither had FHRT and both were delivered vagi-
nally, and had low apgar scores. The two babies born
through thin MSAF who developed HIE were without any
maternal hypertension, no FHRT, and hence both were
delivered vaginally. Apgar score of one was 3 at 5 minutes
but the other had an Apgar score of 8, developed neuro-
motor excitability and excessive crying and later devel-
oped seizures. All controls were born vaginally, 24% (n =
6) with thick MSAF and 18% (n = 5) with thin were born
through Caesarian section.
Postnatally,2 babies born through thin MSAF developed
Group B Streptococcal septicaemia,2 developed respira-
tory distress attributable to aspiration pneumonia, and
one child developed hyperbilirubinaemia requiring pho-
totherapy. In the Thick MSAF Group, 4 developed respira-
Table 1: Characteristics of newborns in the study: 27 newborns with thin MSAF, 25 newborns with thick MSAF and 42 controls
Characteristic Normal infants Infants with MSAF (n = 52)
(n = 42) Thin (n = 27) Thick (n = 25) p- Value$
Birth weight (±SD) 2885.7 ± 374 g 2767.0 ± 289.9 g 2654.8 ± 311 g@ 0.03
Gestational Age (±SD) 40 Wks ± 1.57 Wk 39 Wks ± 2.0 Wks 39 Wks ± 2.0 Wks 0.96
Sex
Male 18 (42.9%) 19 (70.4%) 13 (52.0%)
Female 24 (57.1%) 8 (29.6%) 12 (48.0%) 0.08
Apgar Score
>6 at 5 min 42 (100.0%) 25 (92.5%) 22 (88.0%)
<6 AT 5 min 0 (0.0%) 2 (7.4%) 3 (12.0%) 0.07
Maternal problems
None 38 (90.5%) 25 (92.6%) 13 (52.0%)
Significant maternal problems* 4 (10.0%) 2 (7.4%) 12 (48.0%)@ <0.01
Mode of Delivery
Normal vaginal delivery 39 (92.9%) 18 (66.7%) 16 (64.0%)
Forceps Delivery 3 (7.1%) 4 (14.8%) 3 (12.0%)
Caesarian section 0 (0.0%) 5 (18.5%) 6 (24.0%)@ <0.01
Postnatal problems
None 42 (100%) 23 (85.2%) 18 (72.0%)
Other problems** 0 (0.0%) 4 (14.8%) 7 (28.0%)@ 0.001
Hypoxic Ischaemic Encephalopathy (HIE)
No 42 (100%) 25 (92.6%) 23 (92.0%)
Yes 0 (0.0)% 2 (7.4%) 2 (8.0%) 0.12
*Thick MSAF babies had significantly more antenatal problems – 3 cases of maternal hypertension, 2 cases of gestational diabetes, 3 cases of fetal 
heart rate abnormality (FHRT), 2 cases of breech delivery, and one case each of cephalopelvic disproportion, and intrauterine growth retardation. 
Thin MSAF Babies had fewer problems in the mothers with two cases of hypertension of which one mother also had cephalopelvic disproportion.
**2 children born through Thin MSAF developed Group B Streptococcal septicaemia,2 developed respiratory distress attributable to aspiration 
pneumonia, and one child developed hyperbilirubinaemia requiring phototherapy. In the Thick MSAF Group, 4 developed respiratory distress 
attributable to aspiration pneumonia, 2 developed hyperbilirubinaemia requiring phototherapy and one child had congenital heart disease.
$ Based on One-Way ANOVA/Fisher's Exact test
@Significant difference of thick MSAF group in comparison to controls.BMC Pediatrics 2006, 6:13 http://www.biomedcentral.com/1471-2431/6/13
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tory distress attributable to aspiration pneumonia, 2
developed hyperbilirubinaemia requiring phototherapy
and one child had congenital heart disease. None of the
babies with HIE had any congenital malformation
detected at antenatal ultrasonography, clinical examina-
tion at birth or postnatal cranial ultrasonography.
Table 2 compares the values of lactate, creatinine and L: C
ratios in babies with thin MSAF, thick MSAF and normal
babies. Lactate values are highest in the thin MSAF group
followed by the thick MSAF and controls. Creatinine, on
the other hand, was lowest in the thin MSAF, followed by
thick MSAF and controls. Normal babies had an average
L: C ratio of 0.13 (± 0.09). It can be noted that the L: C
ratio was more among thin MSAF babies (4.3 ± 11.94)
than thick MSAF babies (0.35 ± 0.35). Median L:C ratios
were also higher in the thin MSAF group. Variation in the
values of these parameters is observed to be high in the
thin MSAF group as compared to other groups.
Though there are significant differences in the means of
the three parameters among the three groups, multiple
comparison procedures showed the difference as signifi-
cant only when normal babies were compared to babies
with thin MSAF (Bonferroni corrected p values: lactate
0.02, creatinine 0.01, LC ratio < 0.001). In other words,
differences between thin and thick MSAF groups are not
significant (Bonferroni corrected p values: lactate 0.34,
Creatinine 0.75, LC ratio 0.09) and also that between
thick MSAF and control groups (Bonferroni corrected p
values: lactate 0.90, creatinine: 0.26, LC ratio 0.14). There
was no significant difference between thick MSAF and
controls.
Median values of the three parameters also show similar
pattern in the three groups.
Figure 2 shows distribution of L:C ratios in normal con-
trols and in babies with thin and thick meconium on log-
arithmic scale. No babies in the control group had L:C
ratios of more than 0.64. Five (20%) babies born with
thick meconium had levels above 0.64 and 2 of these
developed HIE stage II during hospital stay. 11 babies
with thin meconium (40%) had levels above the cut-off of
0.64 and among these, HIE developed in the extreme
range of figure at L: C ratio of 58.6 and 93.
Discussion
We have looked at babies who had probable asphyxia
long before the time of birth as indicated by thin meco-
nium, against babies asphyxiated around the time of
birth, indicated by thick meconium [12,20-22]. We found
that the mean L: C ratio in babies with thin meconium
was 12 times higher than in those with thick meconium.
The two highest values in babies with thin meconium was
93 and 58.6, and in those with thick meconium 1.25 and
1.10. It is significant that it is these four babies (two in
each group) who developed convulsions and HIE stage II
during hospital stay.
We found that 7% of babies with thin meconium progress
to HIE stage II during hospital stay. Similar incidence
(6.3%) of severe birth asphyxia (HIE stage II and beyond)
in babies born through thin MSAF has been reported
earlier28. Although, in our series, we had 2 cases of
asphyxia each in babies born through thick and thin
MSAF, babies with thick meconium are known to suffer
more HIE [9,28,29].
As a priori we have assumed that meconium staining of
amnion suggests intrauterine asphyxia. Not all authors are
agreed that this is a maker of distress. Some authors con-
sider the presence of meconium as a physiological event
Table 2: Urine Lactate, Creatinine and L: C Ratio in first passed urine within six hours of birth from normal babies, those with thick 
and thin meconium staining of liquor at birth. (p-values comparing the means by ANOVA on log transformed values
Controls (n = 42) Thin MSAF (n = 27) Thick MSAF (n = 25) P value$
Lactate (mg/dL)
Mean ± SD 3.3 ± 2.79@ 21.6 ± 34.83 5.1 ± 5.34 0.02
Median (IQR) 1.8 (1.30 – 5.05) 6.7 (1.10 – 14.60) 3.5 (1.49 – 6.40)
Creatinine (mg/dL)
Mean ± SD 25.3 ± 10.08@ 17.7 ± 13.32 20.4 ± 13.71 < 0.01
Median (IQR) 26.2 (19.58 – 32.00) 15.7 (7.00 – 25.70) 20.3 (8.50 – 30.80)
L:C Ratio
Mean ± SD 0.13 ± 0.09@ 4.33 ± 11.94 0.35 ± 0.35 < 0.01
Median (IQR) 0.09 (0.06 – 0.18) 0.29 (0.09 – 1.11) 0.23 (0.11 – 0.48)
$ Based on One-way ANOVA
@: Significant difference between Controls and Thin MSAF (on Bonferroni adjusted multiple comparisons).BMC Pediatrics 2006, 6:13 http://www.biomedcentral.com/1471-2431/6/13
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[9,30]. Jazayeri et al [20], and Richey et al [21] reported
much higher levels of fetal erythopoeitin and Carbonne et
al [22] reported fetal anoxia in babies with early passage
of meconium. We have shown high levels of L: C ratio
among babies with thin meconium. We believe that based
on these reports and our findings in this paper, it can be
stated that early passage of meconium suggests chronic
intrauterine asphyxia.
Thin meconium babies show considerable skewness in
their L: C ratio suggesting it to be a heterogeneous group
and the ratio a nonspecific marker of asphyxia in this
group of newborns. A closer scrutiny (Figure 2) shows at
least two groups – one is a compact cluster of babies with
L: C ratios comparable to babies with thick meconium
and no HIE. The other group of babies with L: C ratios,
10–100 times higher than the mean L: C ratio in the pre-
vious cluster and cases of HIE occurred in this extreme
group. The first group probably reflects milder-'compen-
sated' asphyxia whereas the latter group probably suffered
more severe asphyxia. The latter group can perhaps be bet-
ter defined when a combination of other antenatal risk
factors like FHRT, low apgar score at birth, and thin meco-
nium are used along with L:C ratio.
High L: C ratios in babies with thin meconium need a
rational explanation. Lactate is produced by anaerobic
metabolism during an asphyxial insult [31-33] and con-
tinues to be excreted for long after the insult [34]. Creati-
nine excretion is dependent upon glomerular filtration
and is reduced in asphyxia [35] whereas lactate is cleared
partly by hepatic and renal metabolism and partly by
tubular secretion [36] using high capacity H+/monocar-
boxylate cotransporter [37] – operative even in shock [34]
and its excretion is reflective of blood levels rather renal
status. Babies continue to excrete lactate and creatinine
excretion is reduced, the ratios increasing accordingly.
Very high lactate in experimental and clinical asphyxia is
well known [34,38] and L:C ratios 10–100 times the base-
line have been reported previously [26].
The bladder capacity is limited, and repeated voiding
occurs in-utero. Once asphyxia occurs, there is continuous
excretion of lactate for a long time afterwards. High urine
lactate has been seen as much as 48–72 hours after the
insult [26], and raised cerebral lactate has been demon-
strated up to a month after asphyxia [34]. If the asphyxia
occurs early – long before delivery, it may be assumed that
all the urine in the bladder consists of post asphyxial
urine. If on the other hand, asphyxia occurs just before
delivery, the secreted lactate in urine dilutes in the urine
already formed in the bladder and, the overall level may
be lower. A similar sequence occurs with creatinine and
post-asphyxial low-creatinine-urine is diluted in the urine
containing normal creatinine levels. In summary high lac-
tate in thin MSAF babies results from continued excretion
over long periods and a serial accumulation of lactate.
Thin meconium is a common event in obstetric practice
and is generally considered innocuous. We have not
looked at the issue of brain damage in this paper and we
do not offer any suggestion to the contrary. In our sample
of babies with thin meconium, it is those who have L:C
ratio 100 times larger than the cut-off of 0.64 who develop
HIE. A suitable cutoff of L: C ratio for babies with thin
meconium can be evolved by larger studies.
Our study has two important limitations. Firstly, babies
were followed only up to discharge from the nursery, and
no long-term follow-up for HIE is available. It limits the
study from commenting on the issue of brain damage.
Secondly we used a 6-hour cutoff for urine collection. It is
not unusual for normal babies not to pass urine in up to
24 or even 48 hours. The most severely asphyxiated new-
borns are oliguric and may not pass urine for even longer.
The L:C ratio was not studied in them. Studies on
Lactate: Creatinine ratio (L:C ratio) in the normal population  compared against thin and thick meconium stained babies,  logarithmic scale Figure 2
Lactate: Creatinine ratio (L:C ratio) in the normal population 
compared against thin and thick meconium stained babies, 
logarithmic scale. The cutoff for ratio of Huang and Wang 
indicative of HIE (= 0.644) is shown in broken lines and 
means in each population by solid lines. The dark boxes and 
circles represent the babies who developed HIE. HIE devel-
oped in babies with the highest value of L:C ratio. The mean 
L:C ratio in the Thin MSAF group is skewed upwards due to 
outliers but these are the two babies who develop HIE (at 
values, a 100 fold of the cut-off of 0.64)
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ischemia – reperfusion induced cell damage suggest that
the damage is complete by six hours. The "window of
opportunity" for rescue medications thus, is only a few
hours and in no case more than six hours [39]. Therefore
it would perhaps be futile to know about asphyxia outside
of this window of six hours, where interventions may not
be useful.
In this study we used conventional enzymatic methods to
assay lactate and creatinine. Zuppi et al have shown earlier
that lactate levels in urine by conventional enzymatic
methods are comparable to levels by proton NMR spec-
troscopy of urine [40]and that two methods can be used
interchangeably.
In conclusion, we report that babies with thin meconium
normally have much higher L: C ratios and HIE occurs at
much higher levels in this group. Larger studies are
needed to evolve a cut-off that performs with acceptable
sensitivity and specificity in babies with thin meconium.
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